Ad Hoc Advocacy Committee Meeting Wednesday, July 14 (3-4 pm) Agenda: Viral Hepatitis Initiative – City Council Funding FY2022 https://council.nyc.gov/budget/wp-content/uploads/sites/54/2021/06/Fiscal-2022-Schedule-C-Merge-6.30.21.pdf Overall increase in funding lev...
Hep Free NYC Advocacy Committee – Quarterly Meeting Highlights Via Zoom webinar – March 10, 2021 (3 – 5 PM)
Has viral hepatitis impacted your life or the life of someone you care about? Are you willing to share your story to help spur change? The NoHep team is collecting stories about hepatitis and we need your help!
CDC ACIP is undergoing an analysis of evidence and rationale to determine if they should make a recommendation for universal adult hep B vaccination. The decision is important in efforts to increase adult hep B immunization rates. Submit both written and oral public comments fo...
Your email will ensure Council is aware Viral Hepatitis Initiative funding is critical to the communities at risk for Hep B and C in NYC, who have also been hit hardest by the global coronavirus pandemic.
Submit written testimony or testify via Zoom at the March 15 New York City Council Health Committee Hearing on the Mayor’s Preliminary Budget. Register to testify at least 24 hours before the hearing.
Organizations wishing to receive City Council funding in FY 2022 must complete Discretionary Funding application by February 19, 2021.
NYC Council established the Viral Hepatitis Initiative in 2014, to fund community organizations to provide hepatitis B and C prevention, linkage to care and care services.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
The Hepatitis A, B and C in NYC: 2019 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
